A Phase I/II Trial of Intravenous CT-2103 [paclitaxel poliglumex] in Patients With Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma
Phase of Trial: Phase I/II
Latest Information Update: 29 May 2013
At a glance
- Drugs Paclitaxel poliglumex (Primary)
- Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Therapeutic Use
- 17 Dec 2009 Actual end date (Feb 2003 ) added as reported by ClinicalTrials.gov.
- 17 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 19 Sep 2005 New trial record.